Public Fund Semi-Annual Income List Revealed: Outstanding Value of Innovative Drug Allocation

The ranking of public funds' performance in the first half of the year is about to be released, with pharmaceutical funds attracting market attention due to their significant excess returns. Data shows that as of June 18th, pharmaceutical funds have stood out with an average net asset value growth rate of over 19%, occupying nearly half of the top 100 in fund performance rankings for the year, sparking widespread market interest in the pharmaceutical sector, especially in the field of innovative drugs.